CLINUVEL: update on Level II ADR upgrade, Nasdaq uplist 2026 Announcements . Clinical . News 28.04.2026
CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study 2026 Announcements . Clinical . News 24.04.2026